Rodent models of glaucoma

Brain Research Bulletin

Volumn 81, Issue 2-3, 2010, Pages 349-358

  Johnson, Thomas V ^a,b   Tomarev, Stanislav I ^a  

^a NATIONAL EYE INSTITUTE   (United States)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Animal models; Glaucoma; Intraocular pressure; Myocilin; Retina; Retinal ganglion cells; Rodent models

Indexed keywords

AMPA RECEPTOR; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C3; EXCITOTOXIN; GLUTATHIONE; KAINIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PROTEIN BAX; SODIUM CHLORIDE; TRANSCRIPTION FACTOR FOXC1; TRANSCRIPTION FACTOR FOXC2; TRANSCRIPTION FACTOR PAX6; TRANSCRIPTION FACTOR PITX2;

AQUEOUS HUMOR OUTFLOW; ARGON LASER; AXONAL INJURY; CAUTERIZATION; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; EXCITOTOXICITY; EXPERIMENTAL ANIMAL; EXPLANT; GENE MUTATION; GENETIC DISORDER; GENETIC MODEL; GENETIC PREDISPOSITION; GLAUCOMA; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INTERMETHOD COMPARISON; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; MICROINJECTION; MUELLER CELL; NERVE CRUSH; NERVE FIBER TRANSECTION; NONHUMAN; OPTIC NERVE; PRESSURE MEASUREMENT; PRIORITY JOURNAL; REPERFUSION INJURY; RETINA GANGLION CELL; RETINA ISCHEMIA; REVIEW;

ANIMALS; DISEASE MODELS, ANIMAL; GLAUCOMA; HUMANS; INTRAOCULAR PRESSURE; RETINA; RODENTIA;

EID: 73149117531     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2009.04.004     Document Type: Review

References (108)

1. Agarwal N., Agarwal R., Kumar D.M., et al. Comparison of expression profile of neurotrophins and their receptors in primary and transformed rat retinal ganglion cells. Mol. Vis. 13 (2007) 1311-1318
2. Ahmed E., Ma J., Rigas I., et al. Non-invasive tonometry in the mouse. Invest. Ophthalmol. Vis. Sci. 44 (2003) 3336
3. Ahmed F., Brown K.M., Stephan D.A., Morrison J.C., Johnson E.C., and Tomarev S.I. Microarray analysis of changes in mRNA levels in the rat retina after experimental elevation of intraocular pressure. Invest. Ophthalmol. Vis. Sci. 45 (2004) 1247-1258
4. Aihara M., Lindsey J.D., and Weinreb R.N. Experimental mouse ocular hypertension: establishment of the model. Invest. Ophthalmol. Vis. Sci. 44 (2003) 4314-4320
5. Alward W.L., Fingert J.H., Coote M.A., et al. Clinical features associated with mutations in the chromosome 1 open-angle glaucoma gene (GLC1A). N. Engl. J. Med. 338 (1998) 1022-1027
6. Anderson M.G., Libby R.T., Gould D.B., Smith R.S., and John S.W. High-dose radiation with bone marrow transfer prevents neurodegeneration in an inherited glaucoma. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 4566-4571
7. Anderson M.G., Smith R.S., Hawes N.L., et al. Mutations in genes encoding melanosomal proteins cause pigmentary glaucoma in DBA/2J mice. Nat. Genet. 30 (2002) 81-85
8. Barres B.A., Silverstein B.E., Corey D.P., and Chun L.L. Immunological, morphological, and electrophysiological variation among retinal ganglion cells purified by panning. Neuron 1 (1988) 791-803
9. Bayer A.U., Neuhardt T., May A.C., et al. Retinal morphology and ERG response in the DBA/2NNia mouse model of angle-closure glaucoma. Invest. Ophthalmol. Vis. Sci. 42 (2001) 1258-1265
10. Beirowski B., Babetto E., Coleman M.P., and Martin K.R. The WldS gene delays axonal but not somatic degeneration in a rat glaucoma model. Eur. J. Neurosci. 28 (2008) 1166-1179
11. Berkelaar M., Clarke D.B., Wang Y.C., Bray G.M., and Aguayo A.J. Axotomy results in delayed death and apoptosis of retinal ganglion cells in adult rats. J. Neurosci. 14 (1994) 4368-4374
12. Blair M., Pease M.E., Hammond J., et al. Effect of glatiramer acetate on primary and secondary degeneration of retinal ganglion cells in the rat. Invest. Ophthalmol. Vis. Sci. 46 (2005) 884-890
13. Bosco A., Inman D.M., Steele M.R., et al. Reduced retina microglial activation and improved optic nerve integrity with minocycline treatment in the DBA/2J mouse model of glaucoma. Invest. Ophthalmol. Vis. Sci. 49 (2008) 1437-1446
14. Buchi E.R. Cell death in rat retina after pressure-induced ischaemia-reperfusion insult: electron microscopic study II. Outer nuclear layer. Jpn. J. Ophthalmol. 36 (1992) 62-68
15. Buchi E.R. Cell death in the rat retina after a pressure-induced ischaemia-reperfusion insult: an electron microscopic study, I. Ganglion cell layer and inner nuclear layer. Exp. Eye Res. 55 (1992) 605-613
16. Buchi E.R., Suivaizdis I., and Fu J. Pressure-induced retinal ischemia in rats: an experimental model for quantitative study. Ophthalmologica 203 (1991) 138-147
17. Chaudhary P., Ahmed F., and Sharma S.C. MK801-a neuroprotectant in rat hypertensive eyes. Brain Res. 792 (1998) 154-158
18. Chauhan B.C., Levatte T.L., Garnier K.L., et al. Semiquantitative optic nerve grading scheme for determining axonal loss in experimental optic neuropathy. Invest. Ophthalmol. Vis. Sci. 47 (2006) 634-640
19. Chauhan B.C., LeVatte T.L., Jollimore C.A., et al. Model of endothelin-1-induced chronic optic neuropathy in rat. Invest. Ophthalmol. Vis. Sci. 45 (2004) 144-152
20. Cvekl A., and Tamm E.R. Anterior eye development and ocular mesenchyme: new insights from mouse models and human diseases. Bioessays 26 (2004) 374-386
21. De Marco N., Buono M., Troise F., and Diez-Roux G. Optineurin increases cell survival and translocates to the nucleus in a Rab8-dependent manner upon an apoptotic stimulus. J. Biol. Chem. 281 (2006) 16147-16156
22. Dreyer E.B., Zurakowski D., Schumer R.A., Podos S.M., and Lipton S.A. Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma. Arch. Ophthalmol. 114 (1996) 299-305
23. Filippopoulos T., Matsubara A., Danias J., et al. Predictability and limitations of non-invasive murine tonometry: comparison of two devices. Exp. Eye Res. 83 (2006) 194-201
24. Fingert J.H., Stone E.M., Sheffield V.C., and Alward W.L. Myocilin glaucoma. Surv. Ophthalmol. 47 (2002) 547-561
25. Fisher J., Levkovitch-Verbin H., Schori H., et al. Vaccination for neuroprotection in the mouse optic nerve: implications for optic neuropathies. J. Neurosci. 21 (2001) 136-142
26. Fortune B., Bui B.V., Morrison J.C., et al. Selective ganglion cell functional loss in rats with experimental glaucoma. Invest. Ophthalmol. Vis. Sci. 45 (2004) 1854-1862
27. Frassetto L.J., Schlieve C.R., Lieven C.J., et al. Kinase-dependent differentiation of a retinal ganglion cell precursor. Invest. Ophthalmol. Vis. Sci. 47 (2006) 427-438
28. Gaasterland D., and Kupfer C. Experimental glaucoma in the rhesus monkey. Invest. Ophthalmol. 13 (1974) 455-457
29. Garcia-Valenzuela E., Shareef S., Walsh J., and Sharma S.C. Programmed cell death of retinal ganglion cells during experimental glaucoma. Exp. Eye Res. 61 (1995) 33-44
30. Goldblum D., and Mittag T. Prospects for relevant glaucoma models with retinal ganglion cell damage in the rodent eye. Vis. Res. 42 (2002) 471-478
31. Gordon M.O., Beiser J.A., Brandt J.D., et al. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch. Ophthalmol. 120 (2002) 714-720 (discussion, 829-830)
32. Gould D.B., Reedy M., Wilson L.A., Smith R.S., Johnson R.L., and John S.W. Mutant myocilin nonsecretion in vivo is not sufficient to cause glaucoma. Mol. Cell. Biol. 26 (2006) 8427-8436
33. Gould D.B., Smith R.S., and John S.W. Anterior segment development relevant to glaucoma. Int. J. Dev. Biol. 48 (2004) 1015-1029
34. Gross R.L., Ji J., Chang P., et al. A mouse model of elevated intraocular pressure: retina and optic nerve findings. Trans. Am. Ophthalmol. Soc. 101 (2003) 163-169 (discussion 169-171)
35. Grozdanic S.D., Betts D.M., Sakaguchi D.S., Allbaugh R.A., Kwon Y.H., and Kardon R.H. Laser-induced mouse model of chronic ocular hypertension. Invest. Ophthalmol. Vis. Sci. 44 (2003) 4337-4346
36. Harada T., Harada C., Nakamura K., et al. The potential role of glutamate transporters in the pathogenesis of normal tension glaucoma. J. Clin. Invest. 117 (2007) 1763-1770
37. Honkanen R.A., Baruah S., Zimmerman M.B., et al. Vitreous amino acid concentrations in patients with glaucoma undergoing vitrectomy. Arch. Ophthalmol. 121 (2003) 183-188
38. Ittner L.M., Schwerdtfeger K., Kunz T.H., et al. Transgenic mice with ocular overexpression of an adrenomedullin receptor reflect human acute angle-closure glaucoma. Clin. Sci. (Lond.) 114 (2008) 49-58
39. Jakobs T.C., Libby R.T., Ben Y., John S.W., and Masland R.H. Retinal ganglion cell degeneration is topological but not cell type specific in DBA/2J mice. J. Cell. Biol. 171 (2005) 313-325
40. Ji J., Chang P., Pennesi M.E., et al. Effects of elevated intraocular pressure on mouse retinal ganglion cells. Vis. Res. 45 (2005) 169-179
41. Jia L., Cepurna W.O., Johnson E.C., and Morrison J.C. Effect of general anesthetics on IOP in rats with experimental aqueous outflow obstruction. Invest. Ophthalmol. Vis. Sci. 41 (2000) 3415-3419
42. John S.W., Hagaman J.R., MacTaggart T.E., Peng L., and Smithes O. Intraocular pressure in inbred mouse strains. Invest. Ophthalmol. Vis. Sci. 38 (1997) 249-253
43. Johnson E.C., Cepurna W.O., Jia L., and Morrison J.C. The use of cyclodialysis to limit exposure to elevated intraocular pressure in rat glaucoma models. Exp. Eye Res. 83 (2006) 51-60
44. Johnson E.C., Jia L., Cepurna W.O., Doser T.A., and Morrison J.C. Global changes in optic nerve head gene expression after exposure to elevated intraocular pressure in a rat glaucoma model. Invest. Ophthalmol. Vis. Sci. 48 (2007) 3161-3177
45. Johnson T.V., Fan S., and Toris C.B. Rebound tonometry in conscious, conditioned mice avoids the acute and profound effects of anesthesia on intraocular pressure. J. Ocul. Pharmacol. Ther. 24 (2008) 175-185
46. Johnson T.V., and Martin K.R. Development and characterization of an adult retinal explant organotypic tissue culture system as an in vitro intraocular stem cell transplantation model. Invest. Ophthalmol. Vis. Sci. 49 (2008) 3503-3512
47. Ju W.K., Kim K.Y., Angert M., et al. Memantine blocks mitochondrial OPA1 and Cytochrome c release, and subsequent apoptotic cell death in glaucomatous retina. Invest. Ophthalmol. Vis. Sci. 50 (2009) 707-716
48. Kass M.A., Heuer D.K., Higginbotham E.J., et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch. Ophthalmol. 120 (2002) 701-713 (discussion 829-830)
49. Krishnamoorthy R.R., Agarwal P., Prasanna G., et al. Characterization of a transformed rat retinal ganglion cell line. Brain Res. Mol. Brain Res. 86 (2001) 1-12
50. Laquis S., Chaudhary P., and Sharma S.C. The patterns of retinal ganglion cell death in hypertensive eyes. Brain Res. 784 (1998) 100-104
51. Le A., Mukesh B.N., McCarty C.A., and Taylor H.R. Risk factors associated with the incidence of open-angle glaucoma: the visual impairment project. Invest. Ophthalmol. Vis. Sci. 44 (2003) 3783-3789
52. Levkovitch-Verbin H., Harris-Cerruti C., Groner Y., Wheeler L.A., Schwartz M., and Yoles E. RGC death in mice after optic nerve crush injury: oxidative stress and neuroprotection. Invest. Ophthalmol. Vis. Sci. 41 (2000) 4169-4174
53. Levkovitch-Verbin H., Martin K.R., Quigley H.A., Baumrind L.A., Pease M.E., and Valenta D. Measurement of amino acid levels in the vitreous humor of rats after chronic intraocular pressure elevation or optic nerve transection. J. Glaucoma 11 (2002) 396-405
54. Levkovitch-Verbin H., Quigley H.A., Martin K.R., Valenta D., Baumrind L.A., and Pease M.E. Translimbal laser photocoagulation to the trabecular meshwork as a model of glaucoma in rats. Invest. Ophthalmol. Vis. Sci. 43 (2002) 402-410
55. Li Y., Schlamp C.L., Poulsen G.L., Jackson M.W., Griep A.E., and Nickells R.W. p53 regulates apoptotic retinal ganglion cell death induced by N-methyl-d-aspartate. Mol. Vis. 8 (2002) 341-350
56. Li Y., Semaan S.J., Schlamp C.L., and Nickells R.W. Dominant inheritance of retinal ganglion cell resistance to optic nerve crush in mice. BMC Neurosci. 8 (2007) 19
57. Libby R.T., Anderson M.G., Pang I.H., et al. Inherited glaucoma in DBA/2J mice: pertinent disease features for studying the neurodegeneration. Vis. Neurosci. 22 (2005) 637-648
58. Libby R.T., Li Y., Savinova O.V., et al. Susceptibility to neurodegeneration in a glaucoma is modified by Bax gene dosage. PLoS Genet. 1 (2005) 17-26
59. Libby R.T., Smith R.S., Savinova O.V., et al. Modification of ocular defects in mouse developmental glaucoma models by tyrosinase. Science (New York, NY) 299 (2003) 1578-1581
60. Mabuchi F., Lindsey J.D., Aihara M., Mackey M.R., and Weinreb R.N. Optic nerve damage in mice with a targeted type I collagen mutation. Invest. Ophthalmol. Vis. Sci. 45 (2004) 1841-1845
61. Malyukova I., Lee H.S., Fariss R.N., and Tomarev S.I. Mutated mouse and human myocilins have similar properties and do not block general secretory pathway. Invest. Ophthalmol. Vis. Sci. 47 (2006) 206-212
62. Mermoud A., Baerveldt G., Mickler D.S., Wu G.S., and Rao N.A. Animal model for uveitic glaucoma. Graefes Arch. Clin. Exp. Ophthalmol. 232 (1994) 553-560
63. Meyer-Franke A., Kaplan M.R., Pfrieger F.W., and Barres B.A. Characterization of the signaling interactions that promote the survival and growth of developing retinal ganglion cells in culture. Neuron 15 (1995) 805-819
64. Moore C.G., Milne S.T., and Morrison J.C. Noninvasive measurement of rat intraocular pressure with the Tono-Pen. Invest. Ophthalmol. Vis. Sci. 34 (1993) 363-369
65. Moreno M.C., Marcos H., Oscar Croxatto J.J., et al. A new experimental model of glaucoma in rats through intracameral injections of hyaluronic acid. Exp. Eye Res. 81 (2005) 71-80
66. Morrison J.C., Johnson E., and Cepurna W.O. Rat models for glaucoma research. Prog. Brain Res. 173 (2008) 285-301
67. Morrison J.C., Johnson E.C., Cepurna W., and Jia L. Understanding mechanisms of pressure-induced optic nerve damage. Prog. Retin. Eye Res. 24 (2005) 217-240
68. Morrison J.C., Moore C.G., Deppmeier L.M., Gold B.G., Meshul C.K., and Johnson E.C. A rat model of chronic pressure-induced optic nerve damage. Exp. Eye Res. 64 (1997) 85-96
69. Mosinger J.L., and Olney J.W. Photothrombosis-induced ischemic neuronal degeneration in the rat retina. Exp. Neurol. 105 (1989) 110-113
70. Nagaraju M., Saleh M., and Porciatti V. IOP-dependent retinal ganglion cell dysfunction in glaucomatous DBA/2J mice. Invest. Ophthalmol. Vis. Sci. 48 (2007) 4573-4579
71. Otori Y. Use of purified retinal ganglion cells for an in vitro model to study glaucoma. In: Tombran-Tink J., Barnstable C.J., and Shields M.B. (Eds). Ophthalmology Research: Mechanisms of the Glaucomas (2008), Humana Press, Totowa, NJ 601-607
72. Pease M.E., Hammond J.C., and Quigley H.A. Manometric calibration and comparison of TonoLab and TonoPen tonometers in rats with experimental glaucoma and in normal mice. J. Glaucoma 15 (2006) 512-519
73. Quigley H.A., and Broman A.T. The number of people with glaucoma worldwide in 2010 and 2020. Br. J. Ophthalmol. 90 (2006) 262-267
74. Ruiz-Ederra J., and Verkman A.S. Mouse model of sustained elevation in intraocular pressure produced by episcleral vein occlusion. Exp. Eye Res. 82 (2006) 879-884
75. Saeki T., Aihara M., Ohashi M., and Araie M. The efficacy of TonoLab in detecting physiological and pharmacological changes of mouse intraocular pressure--comparison with TonoPen and microneedle manometery. Curr. Eye Res. 33 (2008) 247-252
76. Sasaki T., Watanabe W., Muranishi Y., et al. Elevated intraocular pressure, optic nerve atrophy, and impaired retinal development in ODAG transgenic mice. Invest. Ophthalmol. Vis. Sci. 50 (2009) 242-248
77. Savinova O.V., Sugiyama F., Martin J.E., et al. Intraocular pressure in genetically distinct mice: an update and strain survey. BMC Genet. 2 (2001) 12
78. Schwartz M. Optic nerve crush: protection and regeneration. Brain Res. Bull. 62 (2004) 467-471
79. Seigel G.M. The golden age of retinal cell culture. Mol. Vis. 5 (1999) 4
80. Senatorov V., Malyukova I., Fariss R., et al. Expression of mutated mouse myocilin induces open-angle glaucoma in transgenic mice. J. Neurosci. 26 (2006) 11903-11914
81. Shareef S.R., Garcia-Valenzuela E., Salierno A., Walsh J., and Sharma S.C. Chronic ocular hypertension following episcleral venous occlusion in rats. Exp. Eye Res. 61 (1995) 379-382
82. Smith R.S., Zabaleta A., Kume T., et al. Haploinsufficiency of the transcription factors FOXC1 and FOXC2 results in aberrant ocular development. Hum. Mol. Genet. 9 (2000) 1021-1032
83. Sowden J.C. Molecular and developmental mechanisms of anterior segment dysgenesis. Eye (Lond., England) 21 (2007) 1310-1318
84. Stasi K., Nagel D., Yang X., et al. Complement component 1Q (C1Q) upregulation in retina of murine, primate, and human glaucomatous eyes. Invest. Ophthalmol. Vis. Sci. 47 (2006) 1024-1029
85. Steele M.R., Inman D.M., Calkins D.J., Horner P.J., and Vetter M.L. Microarray analysis of retinal gene expression in the DBA/2J model of glaucoma. Invest. Ophthalmol. Vis. Sci. 47 (2006) 977-985
86. Stefansson E., Wilson C.A., Schoen T., and Kuwabara T. Experimental ischemia induces cell mitosis in the adult rat retina. Invest. Ophthalmol. Vis. Sci. 29 (1988) 1050-1055
87. Stevens B., Allen N.J., Vazquez L.E., et al. The classical complement cascade mediates CNS synapse elimination. Cell 131 (2007) 1164-1178
88. Sun Q., Ooi V.E., and Chan S.O. N-methyl-d-aspartate-induced excitotoxicity in adult rat retina is antagonized by single systemic injection of MK-801. Exp. Brain Res. 138 (2001) 37-45
89. Szabo M.E., Droy-Lefaix M.T., Doly M., Carre C., and Braquet P. Ischemia and reperfusion-induced histologic changes in the rat retina. Demonstration of a free radical-mediated mechanism. Invest. Ophthalmol. Vis. Sci. 32 (1991) 1471-1478
90. Takeshi I., Zai-Long C., Fumie Y., et al. Three potential mouse model for glaucoma. International Congress for Eye Research. Beijing, China (2008) (ICER abstract GL1)
91. Taniguchi T., Okada K., Haque M.S., Sugiyama K., and Kitazawa Y. Effects of endothelin-1 on intraocular pressure and aqueous humor dynamics in the rabbit eye. Curr. Eye Res. 13 (1994) 461-464
92. Thanos S., and Naskar R. Correlation between retinal ganglion cell death and chronically developing inherited glaucoma in a new rat mutant. Exp. Eye Res. 79 (2004) 119-129
93. Ueda J., Sawaguchi S., Hanyu T., et al. Experimental glaucoma model in the rat induced by laser trabecular photocoagulation after an intracameral injection of India ink. Jpn. J. Ophthalmol. 42 (1998) 337-344
94. Urcola J.H., Hernandez M., and Vecino E. Three experimental glaucoma models in rats: comparison of the effects of intraocular pressure elevation on retinal ganglion cell size and death. Exp. Eye Res. 83 (2006) 429-437
95. Vorwerk C.K., Lipton S.A., Zurakowski D., Hyman B.T., Sabel B.A., and Dreyer E.B. Chronic low-dose glutamate is toxic to retinal ganglion cells. Toxicity blocked by memantine. Invest. Ophthalmol. Vis. Sci. 37 (1996) 1618-1624
96. Vrabec J.P., and Levin L.A. The neurobiology of cell death in glaucoma. Eye 21 Suppl. 1 (2007) S11-14
97. Wamsley S., Gabelt B.T., Dahl D.B., et al. Vitreous glutamate concentration and axon loss in monkeys with experimental glaucoma. Arch. Ophthalmol. 123 (2005) 64-70
98. Wang W.H., McNatt L.G., Pang I.H., et al. Increased expression of the WNT antagonist sFRP-1 in glaucoma elevates intraocular pressure. J. Clin. Investig. 118 (2008) 1056-1064
99. Ward M.S., Khoobehi A., Lavik E.B., Langer R., and Young M.J. Neuroprotection of retinal ganglion cells in DBA/2J mice with GDNF-loaded biodegradable microspheres. J. Pharm. Sci. 96 (2007) 558-568
100. Whitmore A.V., Libby R.T., and John S.W. Glaucoma: thinking in new ways-a role for autonomous axonal self-destruction and other compartmentalised processes?. Prog. Retin. Eye Res. 24 (2005) 639-662
101. Wijono M., WoldeMussie E., and Ruiz G. Process of retinal ganglion damage by elevated intraocular pressure in rat eyes. Invest. Ophthalmol. Vis. Sci. 40 (1999) 3545 (ARVO Abstract, S672. Abstract)
102. WoldeMussie E., and Feldman B. Effect of chronically elevated intraocular pressure on loss of retinal ganglion cells in rats. Invest. Ophthalmol. Vis. Sci. 38 (1997) 787 (ARVO Abstract, S159. Abstract)
103. Yang X.L. Characterization of receptors for glutamate and GABA in retinal neurons. Prog. Neurobiol. 73 (2004) 127-150
104. Yoles E., Muller S., and Schwartz M. NMDA-receptor antagonist protects neurons from secondary degeneration after partial optic nerve crush. J. Neurotrauma 14 (1997) 665-675
105. Zhang S.S., Fu X.Y., and Barnstable C.J. Tissue culture studies of retinal development. Methods 28 (2002) 439-447
106. Zhong L., Bradley J., Schubert W., et al. Erythropoietin promotes survival of retinal ganglion cells in DBA/2J glaucoma mice. Invest. Ophthalmol. Vis. Sci. 48 (2007) 1212-1218
107. Zhou X., Li F., Ge J., et al. Retinal ganglion cell protection by 17-beta-estradiol in a mouse model of inherited glaucoma. Dev. Neurobiol. 67 (2007) 603-616
108. Zhou Y., Grinchuk O., and Tomarev S.I. Transgenic mice expressing the Tyr437His mutant of human myocilin protein develop glaucoma. Invest. Ophthalmol. Vis. Sci. 49 (2008) 1932-1939